Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × gedatolisib × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Specimen Handling 38 pembrolizumab 36 Biopsy 34 Magnetic Resonance Spectroscopy 30 Nivolumab 19 Paclitaxel 15 Radiosurgery 11 Gemcitabine 11 Carboplatin 11 trastuzumab deruxtecan 10 Fulvestrant 10 Capecitabine 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Ipilimumab 9 Fluorouracil 9 Cisplatin 9 Drug Therapy 8 Cyclophosphamide 8 Cetuximab 8 130-nm albumin-bound paclitaxel 8 atezolizumab 7 abemaciclib 7 Oxaliplatin 7 palbociclib 6 X-Rays 6 Trastuzumab 6 Standard of Care 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05501886 2026-02-10

VIKTORIA-1

Celcuity Inc

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡